Literature DB >> 406395

5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids.

R A Parker, T Kariya, J M Grisar, V Petrow.   

Abstract

5-(Tetradecyloxy)-2-furancarboxylic acid (91, RMI 14514) was found to lower blood lipids and to inhibit fatty acid synthesis with minimal effects on liver weight and liver fat content. This fatty acid-like compound represents a new class of hypolipidemic agent; it is effective in rats and monkeys. The compound resulted from discovery of hypolipidemic activity in certain beta-keto esters, postulation and confirmation of the corresponding benzoic acids as active metabolites, and systematic exploration of the structure--activity relationships.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406395     DOI: 10.1021/jm00216a009

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  14 in total

Review 1.  Targeting Cancer Metabolism and Current Anti-Cancer Drugs.

Authors:  Witchuda Sukjoi; Jarunya Ngamkham; Paul V Attwood; Sarawut Jitrapakdee
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome.

Authors:  Jun Kusunoki; Akio Kanatani; David E Moller
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Antimicrobial activity of a novel furan fatty acid, 7,10-epoxyoctadeca-7,9-dienoic acid against methicillin-resistant Staphylococcus aureus.

Authors:  Chakradhar Dasagrandhi; Joel B Ellamar; Young Soon Kim; Hak-Ryul Kim
Journal:  Food Sci Biotechnol       Date:  2016-12-31       Impact factor: 2.391

4.  The role of ATP citrate-lyase in the metabolic regulation of plasma lipids. Hypolipidaemic effects of SB-204990, a lactone prodrug of the potent ATP citrate-lyase inhibitor SB-201076.

Authors:  N J Pearce; J W Yates; T A Berkhout; B Jackson; D Tew; H Boyd; P Camilleri; P Sweeney; A D Gribble; A Shaw; P H Groot
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

5.  Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoic acid.

Authors:  D L Halvorson; S A McCune
Journal:  Lipids       Date:  1984-11       Impact factor: 1.880

6.  AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism.

Authors:  Stephen L Pinkosky; Sergey Filippov; Rai Ajit K Srivastava; Jeffrey C Hanselman; Cheryl D Bradshaw; Timothy R Hurley; Clay T Cramer; Mark A Spahr; Ashley F Brant; Jacob L Houghton; Chris Baker; Mark Naples; Khosrow Adeli; Roger S Newton
Journal:  J Lipid Res       Date:  2012-11-01       Impact factor: 5.922

7.  The hypolipidemic activity of furoic Acid and furylacrylic Acid derivatives in rodents.

Authors:  I H Hall; W L Williams; K A Rhyne; M Knowles
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

8.  The hypolipidemic activity of 3-iminophthalimidine in rodents.

Authors:  P J Voorstad; G H Cocolas; I H Hall
Journal:  Pharm Res       Date:  1984-11       Impact factor: 4.200

9.  4-(Benz-yloxy)phenyl 4-hexa-dec-yloxy-3-meth-oxy-benzoate.

Authors:  Waleed Fadl Ali Al-Eryani; H T Srinivasa; S Jeyaseelan; T Sadashivaiah; H C Devarajegowda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-03-12

10.  Unusual responses of rat hepatic and renal peroxisomes to RMI 14, 514, a new hypolipidemic agent.

Authors:  D J Svoboda
Journal:  J Cell Biol       Date:  1978-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.